Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

November 01, 1993; Volume 21,Issue 6
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abbott, F

    1. You have access
      In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.
      K Kassahun and F Abbott
      Drug Metabolism and Disposition November 1993, 21 (6) 1098-1106;
  2. Adusumalli, V E

    1. You have access
      Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
      V E Adusumalli, J K Wichmann, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition November 1993, 21 (6) 1079-1085;
  3. Alberts, D W

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;
  4. Andoh, K

    1. You have access
      Pharmacokinetic study of p-chloronitrobenzene in humans suffering from acute poisoning.
      T Yoshida, T Tabuchi and K Andoh
      Drug Metabolism and Disposition November 1993, 21 (6) 1142-1146;

B

  1. Baba, T

    1. You have access
      Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;
  2. Baker, M T

    1. You have access
      Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;
  3. Bandyopadhyay, A M

    1. You have access
      Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;
  4. Barrow, A

    1. You have access
      Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;
  5. Bekersky, I

    1. You have access
      Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition November 1993, 21 (6) 1017-1021;
  6. Berger, Y

    1. You have access
      Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;
  7. Bertin, D

    1. You have access
      In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;
  8. Bishop, J B

    1. You have access
      Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;
  9. Black, A

    1. You have access
      Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;
  10. Blouin, R A

    1. You have access
      Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;
  11. Bogdanffy, M S

    1. You have access
      Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate.
      M S Bogdanffy and M L Taylor
      Drug Metabolism and Disposition November 1993, 21 (6) 1107-1111;
  12. Bolton, M G

    1. You have access
      Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;
  13. Boutin, J A

    1. You have access
      In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;
  14. Brouwer, K L

    1. You have access
      Acute phenobarbital administration alters the disposition of acetaminophen metabolites in the rat.
      K L Brouwer
      Drug Metabolism and Disposition November 1993, 21 (6) 1129-1133;

C

  1. Castle, M C

    1. You have access
      Formation of a beta-glucuronidase-resistant glucuronide conjugate of digitoxin by dog liver microsomes.
      M C Castle
      Drug Metabolism and Disposition November 1993, 21 (6) 1147-1150;
  2. Chang, T

    1. You have access
      Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;
  3. Chauret, N

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;
  4. Chiang, C K

    1. You have access
      Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;
  5. Chui, Y C

    1. You have access
      Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;
  6. Chung, J G

    1. You have access
      Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
      J G Chung, G N Levy and W W Weber
      Drug Metabolism and Disposition November 1993, 21 (6) 1057-1063;
  7. Coddington, A B

    1. You have access
      Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
      L E Los, A B Coddington, H G Ramjit and H D Colby
      Drug Metabolism and Disposition November 1993, 21 (6) 1086-1090;
  8. Coe, R A

    1. You have access
      Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;
  9. Colby, H D

    1. You have access
      Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
      L E Los, A B Coddington, H G Ramjit and H D Colby
      Drug Metabolism and Disposition November 1993, 21 (6) 1086-1090;
  10. Colthup, P V

    1. You have access
      Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;
  11. Colvin, O M

    1. You have access
      Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;

D

  1. Drey, J M

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;
  2. Duggan, D E

    1. You have access
      Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

F

  1. Fabre, G

    1. You have access
      Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;
  2. Farinotti, R

    1. You have access
      Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;
  3. Feng, R

    1. You have access
      Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;
  4. Fernandez, C

    1. You have access
      Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;
  5. Fujioka, M

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;
  6. Fujita, S

    1. You have access
      Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;
  7. Fujitsu, T

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

G

  1. Gilbert, P J

    1. You have access
      Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;
  2. Gimenez, F

    1. You have access
      Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;
  3. Gires, P

    1. You have access
      Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;
  4. Gonzalez, F J

    1. You have access
      Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;
  5. Grossman, S J

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;
  6. Guengerich, F P

    1. You have access
      Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;

H

  1. Halpin, R A

    1. You have access
      Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;
  2. Hamilton, R

    1. You have access
      Relationship between the terminal disposition half-life and mean residence time in multicompartment models.
      M Mayersohn and R Hamilton
      Drug Metabolism and Disposition November 1993, 21 (6) 1172-1173;
  3. Hanson, G

    1. You have access
      Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition November 1993, 21 (6) 1017-1021;
  4. Hartley, T E

    1. You have access
      Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;
  5. Hendrickx, J

    1. You have access
      Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;
  6. Hennig, P

    1. You have access
      In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;
  7. Herold, E G

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;
  8. Heykants, J

    1. You have access
      Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;
  9. Hillbeck, D

    1. You have access
      Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;
  10. Hilton, J

    1. You have access
      Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;
  11. Huang, M L

    1. You have access
      Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;
  12. Hunninghake, D B

    1. You have access
      Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

I

  1. Inui, Y

    1. You have access
      Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;
  2. Iwasaki, K

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;

J

  1. Jarman, M

    1. You have access
      Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;
  2. Joyeux, H

    1. You have access
      Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;
  3. Julian, B

    1. You have access
      Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;

K

  1. Kagimoto, N

    1. You have access
      Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;
  2. Kari, P H

    1. You have access
      Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;
  3. Kassahun, K

    1. You have access
      In vivo formation of the thiol conjugates of reactive metabolites of 4-ene VPA and its analog 4-pentenoic acid.
      K Kassahun and F Abbott
      Drug Metabolism and Disposition November 1993, 21 (6) 1098-1106;
  4. Kucharczyk, N

    1. You have access
      Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
      V E Adusumalli, J K Wichmann, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition November 1993, 21 (6) 1079-1085;
  5. Kulkarni, S

    1. You have access
      Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

L

  1. Lambert, P H

    1. You have access
      In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;
  2. Lee, H

    1. You have access
      Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;
  3. Levy, G N

    1. You have access
      Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
      J G Chung, G N Levy and W W Weber
      Drug Metabolism and Disposition November 1993, 21 (6) 1057-1063;
  4. Lłnning, P E

    1. You have access
      Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;
  5. Los, L E

    1. You have access
      Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
      L E Los, A B Coddington, H G Ramjit and H D Colby
      Drug Metabolism and Disposition November 1993, 21 (6) 1086-1090;

M

  1. Maconochie, J G

    1. You have access
      Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;
  2. Manchee, G R

    1. You have access
      Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;
  3. Mannens, G

    1. You have access
      Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;
  4. Maradeix, V

    1. You have access
      Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;
  5. Martinet, M

    1. You have access
      Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;
  6. Masubuchi, Y

    1. You have access
      Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;
  7. Mather, L E

    1. You have access
      Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;
  8. Mayersohn, M

    1. You have access
      Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;
    2. You have access
      Relationship between the terminal disposition half-life and mean residence time in multicompartment models.
      M Mayersohn and R Hamilton
      Drug Metabolism and Disposition November 1993, 21 (6) 1172-1173;
  9. McCague, R

    1. You have access
      Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;
  10. McClain, C J

    1. You have access
      Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;
  11. McLean, C F

    1. You have access
      Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;
  12. McNally, W

    1. You have access
      Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;
  13. Meuldermans, W

    1. You have access
      Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;
  14. Meunier, F

    1. You have access
      In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;
  15. Milne, R W

    1. You have access
      Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;
  16. Mimura, M

    1. You have access
      Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;
  17. Mong, S

    1. You have access
      Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition November 1993, 21 (6) 1017-1021;
  18. Mulder, G J

    1. You have access
      Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
      Y Zhao, C A Snel, G J Mulder and K S Pang
      Drug Metabolism and Disposition November 1993, 21 (6) 1070-1078;

N

  1. Nagase, K

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;
  2. Nakatsuka, I

    1. You have access
      Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
      M Yabuki, F Shono, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition November 1993, 21 (6) 1167-1169;
  3. Narimatsu, S

    1. You have access
      Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;
  4. Nation, R L

    1. You have access
      Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;
  5. Nicoll-Griffith, D

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;
  6. Noda, K

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;
  7. Noe, D A

    1. You have access
      Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;

O

  1. Ohmori, S

    1. You have access
      Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;
  2. Oxford, J

    1. You have access
      Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;

P

  1. Palmer, E

    1. You have access
      Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;
  2. Pang, K S

    1. You have access
      Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
      Y Zhao, C A Snel, G J Mulder and K S Pang
      Drug Metabolism and Disposition November 1993, 21 (6) 1070-1078;
  3. Patrick, D H

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;
  4. Poon, G K

    1. You have access
      Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;
  5. Puhl, R J

    1. You have access
      Disposition of a new antiinfective agent 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in male rats.
      I Bekersky, R J Puhl, G Hanson and S Mong
      Drug Metabolism and Disposition November 1993, 21 (6) 1017-1021;

R

  1. Ramjit, H G

    1. You have access
      Identification of spironolactone metabolites in plasma and target organs of guinea pigs.
      L E Los, A B Coddington, H G Ramjit and H D Colby
      Drug Metabolism and Disposition November 1993, 21 (6) 1086-1090;
  2. Redureau, M

    1. You have access
      Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;
  3. Robertson, K D

    1. You have access
      Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;
  4. Ronnenberg, W C

    1. You have access
      Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;
  5. Rowlands, M G

    1. You have access
      Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
      G K Poon, Y C Chui, R McCague, P E Lłnning, R Feng, M G Rowlands and M Jarman
      Drug Metabolism and Disposition November 1993, 21 (6) 1119-1124;
  6. Runciman, W B

    1. You have access
      Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;
  7. Rutten, A J

    1. You have access
      Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;
  8. Ruzicka, J A

    1. You have access
      Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;

S

  1. Sabouraud, A

    1. You have access
      Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;
  2. Saint-Aubert, B

    1. You have access
      Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions.
      G Fabre, B Julian, B Saint-Aubert, H Joyeux and Y Berger
      Drug Metabolism and Disposition November 1993, 21 (6) 978-985;
  3. Sakuma, S

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;
  4. Sato, A

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;
  5. Scherrmann, J M

    1. You have access
      Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
      A Sabouraud, M Redureau, P Gires, M Martinet and J M Scherrmann
      Drug Metabolism and Disposition November 1993, 21 (6) 997-1002;
  6. Serkiz, B

    1. You have access
      In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;
  7. Shedlofsky, S I

    1. You have access
      Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;
  8. Shimada, T

    1. You have access
      Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;
  9. Shimatani, K

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;
  10. Shiraga, T

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;
  11. Shono, F

    1. You have access
      Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
      M Yabuki, F Shono, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition November 1993, 21 (6) 1167-1169;
  12. Shum, Y Y

    1. You have access
      Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;
  13. Sipes, I G

    1. You have access
      Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;
  14. Sloan, P A

    1. You have access
      Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;
  15. Snel, C A

    1. You have access
      Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
      Y Zhao, C A Snel, G J Mulder and K S Pang
      Drug Metabolism and Disposition November 1993, 21 (6) 1070-1078;
  16. Sofia, R D

    1. You have access
      Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
      V E Adusumalli, J K Wichmann, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition November 1993, 21 (6) 1079-1085;
  17. Somogyi, A A

    1. You have access
      Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
      R W Milne, P A Sloan, C F McLean, L E Mather, R L Nation, W B Runciman, A J Rutten and A A Somogyi
      Drug Metabolism and Disposition November 1993, 21 (6) 1151-1156;
  18. Streeper, R T

    1. You have access
      Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione.
      M G Bolton, J Hilton, K D Robertson, R T Streeper, O M Colvin and D A Noe
      Drug Metabolism and Disposition November 1993, 21 (6) 986-996;
  19. Suzuki, T

    1. You have access
      Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
      Y Masubuchi, N Kagimoto, S Narimatsu, S Fujita and T Suzuki
      Drug Metabolism and Disposition November 1993, 21 (6) 1012-1016;

T

  1. Tabuchi, T

    1. You have access
      Pharmacokinetic study of p-chloronitrobenzene in humans suffering from acute poisoning.
      T Yoshida, T Tabuchi and K Andoh
      Drug Metabolism and Disposition November 1993, 21 (6) 1142-1146;
  2. Tarbit, M H

    1. You have access
      Disposition of salmeterol xinafoate in laboratory animals and humans.
      G R Manchee, A Barrow, S Kulkarni, E Palmer, J Oxford, P V Colthup, J G Maconochie and M H Tarbit
      Drug Metabolism and Disposition November 1993, 21 (6) 1022-1028;
  3. Taylor, M L

    1. You have access
      Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate.
      M S Bogdanffy and M L Taylor
      Drug Metabolism and Disposition November 1993, 21 (6) 1107-1111;
  4. Thuillier, A

    1. You have access
      Pharmacokinetics of zopiclone and its enantiomers in Caucasian young healthy volunteers.
      C Fernandez, V Maradeix, F Gimenez, A Thuillier and R Farinotti
      Drug Metabolism and Disposition November 1993, 21 (6) 1125-1128;
  5. Till, A E

    1. You have access
      Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;
  6. Tinker, J H

    1. You have access
      Inhibitory effects of deuterium substitution on the metabolism of sevoflurane by the rat.
      M T Baker, W C Ronnenberg, J A Ruzicka, C K Chiang and J H Tinker
      Drug Metabolism and Disposition November 1993, 21 (6) 1170-1171;
  7. Toler, S M

    1. You have access
      Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;
  8. Tozuka, Z

    1. You have access
      Isolation, identification, and biological activities of oxidative metabolites of FK506, a potent immunosuppressive macrolide lactone.
      K Iwasaki, T Shiraga, K Nagase, Z Tozuka, K Noda, S Sakuma, T Fujitsu, K Shimatani, A Sato and M Fujioka
      Drug Metabolism and Disposition November 1993, 21 (6) 971-977;
  9. Troke, J A

    1. You have access
      Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;
  10. Turcan, R G

    1. You have access
      Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;

U

  1. Ulm, E H

    1. You have access
      Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;
  2. Umbenhauer, D R

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;

V

  1. Volland, J P

    1. You have access
      In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats.
      J A Boutin, F Meunier, P H Lambert, P Hennig, D Bertin, B Serkiz and J P Volland
      Drug Metabolism and Disposition November 1993, 21 (6) 1157-1166;
  2. Vose, C W

    1. You have access
      Disposition of [14C]velnacrine maleate in rats, dogs, and humans.
      R G Turcan, D Hillbeck, T E Hartley, P J Gilbert, R A Coe, J A Troke and C W Vose
      Drug Metabolism and Disposition November 1993, 21 (6) 1037-1047;
  3. Vyas, K P

    1. You have access
      Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.
      R A Halpin, E H Ulm, A E Till, P H Kari, K P Vyas, D B Hunninghake and D E Duggan
      Drug Metabolism and Disposition November 1993, 21 (6) 1003-1011;

W

  1. Weber, W W

    1. You have access
      Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice.
      J G Chung, G N Levy and W W Weber
      Drug Metabolism and Disposition November 1993, 21 (6) 1057-1063;
  2. Wichmann, J K

    1. You have access
      Distribution of the anticonvulsant felbamate to cerebrospinal fluid and brain tissue of adult and neonatal rats.
      V E Adusumalli, J K Wichmann, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition November 1993, 21 (6) 1079-1085;
  3. Winter, S M

    1. You have access
      Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;
  4. Woestenborghs, R

    1. You have access
      Absorption, metabolism, and excretion of risperidone in humans.
      G Mannens, M L Huang, W Meuldermans, J Hendrickx, R Woestenborghs and J Heykants
      Drug Metabolism and Disposition November 1993, 21 (6) 1134-1141;
  5. Woolf, T F

    1. You have access
      Biodisposition studies with the acyl-coenzyme A: cholesterol acyltransferase inhibitor 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide, CI-976.
      T F Woolf, A Black, Y Y Shum, W McNally, H Lee and T Chang
      Drug Metabolism and Disposition November 1993, 21 (6) 1112-1118;

Y

  1. Yabuki, M

    1. You have access
      Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
      M Yabuki, F Shono, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition November 1993, 21 (6) 1167-1169;
  2. Yamazaki, H

    1. You have access
      Characterization of cytochrome P-450 2B6 in human liver microsomes.
      M Mimura, T Baba, H Yamazaki, S Ohmori, Y Inui, F J Gonzalez, F P Guengerich and T Shimada
      Drug Metabolism and Disposition November 1993, 21 (6) 1048-1056;
  3. Yergey, J A

    1. You have access
      CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans.
      S J Grossman, E G Herold, J M Drey, D W Alberts, D R Umbenhauer, D H Patrick, D Nicoll-Griffith, N Chauret and J A Yergey
      Drug Metabolism and Disposition November 1993, 21 (6) 1029-1036;
  4. Yoshida, T

    1. You have access
      Pharmacokinetic study of p-chloronitrobenzene in humans suffering from acute poisoning.
      T Yoshida, T Tabuchi and K Andoh
      Drug Metabolism and Disposition November 1993, 21 (6) 1142-1146;
  5. Yoshitake, A

    1. You have access
      Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist.
      M Yabuki, F Shono, I Nakatsuka and A Yoshitake
      Drug Metabolism and Disposition November 1993, 21 (6) 1167-1169;
  6. Young, A B

    1. You have access
      Head injury and cytochrome P-450 enzymes. Differential effect on mRNA and protein expression in the Fischer-344 rat.
      S M Toler, A B Young, C J McClain, S I Shedlofsky, A M Bandyopadhyay and R A Blouin
      Drug Metabolism and Disposition November 1993, 21 (6) 1064-1069;

Z

  1. Zhao, Y

    1. You have access
      Localization of glutathione conjugation activities toward bromosulfophthalein in perfused rat liver. Studies with the multiple indicator dilution technique.
      Y Zhao, C A Snel, G J Mulder and K S Pang
      Drug Metabolism and Disposition November 1993, 21 (6) 1070-1078;
  2. Zheng, W

    1. You have access
      Toxicokinetics of sulfasalazine (salicylazosulfapyridine) and its metabolites in B6C3F1 mice.
      W Zheng, S M Winter, M Mayersohn, J B Bishop and I G Sipes
      Drug Metabolism and Disposition November 1993, 21 (6) 1091-1097;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 21, Issue 6
1 Nov 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics